Related Experiment Video

Updated: Aug 14, 2026

Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
08:37

Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice

Published on: April 21, 2015

Activated CD19+ B cell lamina propria lymphocytes in ulcerative colitis

B R Yacyshyn1

  • 1Department of Medicine, University of Alberta, Edmonton, Canada.

Immunology and Cell Biology
|August 1, 1993
PubMed

Insights

B cells in ulcerative colitis (UC) show higher activation markers, including CD71, CD25, and 4F2, compared to Crohn's disease or normal tissues. This suggests increased transitional B cells in UC, potentially linking B cell activation to immunoglobulin differences in inflammatory bowel disease.

Area of Science:

  • Immunology
  • Gastroenterology
  • Cell Biology

Background:

  • Isotype differences in immunoglobulin production by lamina propria lymphocytes (LPL) are known in ulcerative colitis (UC) and Crohn's disease (CD).
  • B cell activation differences between normal individuals and patients with inflammatory bowel disease (IBD) have not been well-described.

Purpose of the Study:

  • To investigate and compare B cell activation in the LPL of patients with UC, CD, and normal controls.
  • To explore the relationship between B cell activation status and immunoglobulin production in IBD.

Main Methods:

  • Flow cytometry was used to analyze B cell activation markers (CD71, CD25, 4F2) on LPLs.
  • Transitional B cells were identified by co-expression of CD45RA and CD45RO.

Main Results:

  • UC LPLs exhibited significantly higher expression of CD71, CD25, and 4F2 on CD19+ B cells compared to CD and normal LPLs.
  • A greater proportion of transitional B cells (CD45RA+/CD45RO+) was observed in UC LPLs.
  • Findings support the role of CD45 isoform transition in CD19 B cell activation.

Conclusions:

  • UC LPL B cells display a heightened state of activation compared to those in CD and normal individuals.
  • Increased B cell activation in UC may contribute to distinct immunoglobulin production patterns observed in IBD.
  • These findings may hold diagnostic and pathophysiological significance for IBD research.

More Related Videos

Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells06:57

Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells

Published on: September 18, 2016

Isolation of Lamina Propria Mononuclear Cells from Murine Colon Using Collagenase E09:48

Isolation of Lamina Propria Mononuclear Cells from Murine Colon Using Collagenase E

Published on: September 26, 2019

Related Concept Videos

Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation. 
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...